标题
Mechanisms of vancomycin resistance in Staphylococcus aureus
作者
关键词
-
出版物
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 7, Pages 2836-2840
出版商
American Society for Clinical Investigation
发表日期
2014-07-02
DOI
10.1172/jci68834
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Comprehensive Identification of Mutations Responsible for Heterogeneous Vancomycin-Intermediate Staphylococcus aureus (hVISA)-to-VISA Conversion in Laboratory-Generated VISA Strains Derived from hVISA Clinical Strain Mu3
- (2013) Miki Matsuo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Decreased Vancomycin Susceptibility in Staphylococcus aureus Caused by IS256Tempering of WalKR Expression
- (2013) Christopher R. E. McEvoy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Is It Time to Replace Vancomycin in the Treatment of Methicillin-Resistant Staphylococcus aureus Infections?
- (2013) S. J. van Hal et al. CLINICAL INFECTIOUS DISEASES
- The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA
- (2013) Benjamin P. Howden et al. INFECTION GENETICS AND EVOLUTION
- In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?
- (2013) S. J. van Hal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing
- (2013) C.-J. Chen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Report of the 13th Vancomycin-Resistant Staphylococcus aureus Isolate from the United States
- (2013) B. M. Limbago et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Alternative Mutational Pathways to Intermediate Resistance to Vancomycin in Methicillin-Resistant Staphylococcus aureus
- (2013) Celine Vidaillac et al. JOURNAL OF INFECTIOUS DISEASES
- First case of infection with vancomycin-resistant Staphylococcus aureus in Europe
- (2013) José Melo-Cristino et al. LANCET
- Contribution of Selected Gene Mutations to Resistance in Clinical Isolates of Vancomycin-Intermediate Staphylococcus aureus
- (2012) Cory Hafer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Mutation in the PP2C Phosphatase Gene in a Staphylococcus aureus USA300 Clinical Isolate with Reduced Susceptibility to Vancomycin and Daptomycin
- (2012) Karla D. Passalacqua et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin-Resistant Staphylococcus aureus, Vancomycin-Intermediate S. aureus, High Vancomycin MIC, and Outcome in Serious S. aureus Infections
- (2012) N. E. Holmes et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The RpoB H481Y Rifampicin Resistance Mutation and an Active Stringent Response Reduce Virulence and Increase Resistance to Innate Immune Responses in Staphylococcus aureus
- (2012) Wei Gao et al. JOURNAL OF INFECTIOUS DISEASES
- Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
- (2012) David R. Cameron et al. JOURNAL OF INFECTIOUS DISEASES
- Comparative Genomics of Vancomycin-Resistant Staphylococcus aureus Strains and Their Positions within the Clade Most Commonly Associated with Methicillin-Resistant S. aureus Hospital-Acquired Infection in the United States
- (2012) V. N. Kos et al. mBio
- Genetic Pathway in Acquisition and Loss of Vancomycin Resistance in a Methicillin Resistant Staphylococcus aureus (MRSA) Strain of Clonal Type USA300
- (2012) Susana Gardete et al. PLoS Pathogens
- walKandclpPMutations Confer Reduced Vancomycin Susceptibility inStaphylococcus aureus
- (2011) Mitsutaka Shoji et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes
- (2011) D. R. Cameron et al. CLINICAL INFECTIOUS DISEASES
- Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus
- (2011) Yukiko Watanabe et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Vancomycin Minimum Inhibitory Concentration and Outcome in Patients With Staphylococcus aureus Bacteremia: Pearl or Pellet?
- (2011) T. L. Holland et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR
- (2011) Benjamin P. Howden et al. PLoS Pathogens
- Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
- (2010) B. P. Howden et al. CLINICAL MICROBIOLOGY REVIEWS
- Contribution of vraSR and graSR Point Mutations to Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus
- (2009) L. Cui et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
- (2009) K. C. Horne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Development of Reduced Vancomycin Susceptibility in Methicillin‐SusceptibleStaphylococcus aureus
- (2009) Satish K. Pillai et al. CLINICAL INFECTIOUS DISEASES
- Paradoxical Relationship between the Clinical Outcome ofStaphylococcus aureusBacteremia and the Minimum Inhibitory Concentration of Vancomycin
- (2009) James Price et al. CLINICAL INFECTIOUS DISEASES
- Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR
- (2009) Y. Kato et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era
- (2009) Frank R. DeLeo et al. JOURNAL OF CLINICAL INVESTIGATION
- Reduced Susceptibility to Vancomycin Influences Pathogenicity inStaphylococcus aureusInfection
- (2009) Anton Y. Peleg et al. JOURNAL OF INFECTIOUS DISEASES
- Is High Vancomycin Minimum Inhibitory Concentration a Good Marker to Predict the Outcome of Methicillin‐ResistantStaphylococcus aureusBacteremia?
- (2009) Antonio Lalueza et al. JOURNAL OF INFECTIOUS DISEASES
- Genomic Analysis Reveals a Point Mutation in the Two-Component Sensor Gene graS That Leads to Intermediate Vancomycin Resistance in Clinical Staphylococcus aureus
- (2008) B. P. Howden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
- (2008) D. M. Sievert et al. CLINICAL INFECTIOUS DISEASES
- Occurrence of a USA300 vancomycin-intermediate Staphylococcus aureus
- (2008) Jeffrey C. Hageman et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Identification of the First Vancomycin Intermediate-Resistant Staphylococcus aureus (VISA) Isolate from a Hospital in Portugal
- (2008) S. Gardete et al. Microbial Drug Resistance
- Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis
- (2008) Paul A. Majcherczyk et al. MICROBIAL PATHOGENESIS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started